-
Product Insights
Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hematopoietic Stem Cell Transplantation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hematopoietic Stem Cell Transplantation, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Inflammation, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Liver Transplant Rejection Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Liver Transplant Rejection Global Clinical Trials Review, H1, 2020" provides an overview of Liver Transplant Rejection Clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Heart Transplant Rejection Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H1, 2020" provides an overview of Heart Transplant Rejection Clinical trials scenario. This report provides top line data relating to the clinical trials on Heart Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Peanut Allergy Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Peanut Allergy Global Clinical Trials Review, H1, 2020" provides an overview of Peanut Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on Peanut Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Graft-Versus-Host Disease - Epidemiology Forecast in Asia-Pacific Markets to 2028
GvHD is a common complication of allogeneic HSCT that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GvHD can progress from mild to severe forms as either aGvHD or cGvHD. Both aGvHD and cGvHD commonly affect organs such as the skin, gastrointestinal (GI) tract, liver, oral mucosa, and eyes. The global distribution of GvHD is directly dependent on transplantation-related factors, including the donor type, the age of the donor and the recipient, the...
-
Product Insights
Grass Pollen Allergy Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Grass Pollen Allergy Global Clinical Trials Review, H1, 2020" provides an overview of Grass Pollen Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on Grass Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Myasthenia Gravis Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2020" provides an overview of Myasthenia Gravis Clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia Gravis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Lung Transplant Rejection Disease - Global Clinical Trials Review, H2 2020
GlobalData's clinical trial report, “Lung Transplant Rejection Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Lung Transplant Rejection Clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor...
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Disease - Global Clinical Trials Review, H2 2020
GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.